Results 121 to 130 of about 43,404 (216)

Skin cancer burden in lung transplant recipients:we need to do better! [PDF]

, 2020
Harwood, C. A., Proby, C. M.
core   +2 more sources

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child [PDF]

, 2018
Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary ...
Aebi, Christoph, Aebischer, Carmen, Ammann, Roland, Gugger, Mathias, Jaton, Katia, Ritz, Nicole, Schmid, Ralph   +6 more
core  

Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods, [and] Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes [PDF]

, 2010
Rapport de synthèse1. Partie de laboratoireCette première étude décrit le développement et la validation, selon les standards internationaux, de deux techniques de mesure des concentrations sanguines de voriconazole, un nouvel agent antifongique à large ...
Pascual, A.
core  

The Effect of Rifapentine and Rifampicin on Serum Voriconazole Levels Persist for 5 Days and 7 Days or More After Discontinuation in Tuberculosis Patients with Chronic Pulmonary Aspergillosis

Infection and Drug Resistance
Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H, Mao Y, Zeng Y, Li P, Yan P, Shi Q, Liu L   +6 more
doaj  

Therapeutic drug monitoring of voriconazole : validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography [PDF]

, 2015
Cattoir, Lien, Degandt, Simon, Fauvarque, Grégoire, Ghys, Timothy, Stove, Veronique, Verstraete, Alain   +5 more
core   +1 more source

A Retrospective, Comparative Cohort Analysis of the Utilization of Voriconazole-Containing Regimens Versus Itraconazole in the Treatment of Blastomycosis

Journal of Fungi
Itraconazole is the recommended first-line antifungal agent in blastomycosis treatment. However, pharmacokinetic limitations and adverse drug events may necessitate the use of alternative antifungal agents.
Caitlin C. Schanz, Christina G. Rivera, Omar M. Abu Saleh, Josh Clement, Mark J. Enzler, Danielle Firkus, Kristin Cole, Paschalis Vergidis, Ryan W. Stevens   +8 more
doaj   +1 more source

In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method. [PDF]

, 2010
The in vitro susceptibility of clinical Candida isolates towards fluconazole and voriconazole was determined using the E-test method. A total of 41 clinical isolates recovered from patients since 2004 until 2009 from two local hospitals in Kuala Lumpur ...
Chong, Pei Pei, Jamal, Farida Fatema @ Farida, Madhavan, Priya, Ng, Kee Peng   +3 more
core  

Voriconazole

Drugs in R & D, 1999
openaire   +2 more sources

Clinical experience treating Paecilomyces lilacinus keratitis in four patients

Clinical Ophthalmology, 2012
Yu Monden,1 Minoru Sugita,1 Ryoji Yamakawa,1 Kazuko Nishimura,21Department of Ophthalmology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; 2Medical Mycology Research Center, Chiba University and First Laboratories Co Ltd, Kawasaki ...
Monden Y, Sugita M, Yamakawa R, Nishimura K   +3 more
doaj  

Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. [PDF]

Crit Care
Coste A, Aubron C, Ansart S, Roberts J, Morio F, Grégoire M.   +5 more
europepmc   +1 more source